Navigation Links
Cepheid to Present at Cowen and Company's 28th Annual Healthcare Conference
Date:3/10/2008

SUNNYVALE, Calif., March 10 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) will present at Cowen and Company's 28th Annual Healthcare Conference on March 18 at 10:15 a.m. ET at The Boston Marriott Copley Place in Boston. John L. Bishop, Chief Executive Officer, will provide a corporate overview.

The webcast, along with accompanying presentation slides, may be accessed on Cepheid's Web site at http://www.cepheid.com under Investors: Events: Webcasts and Presentations. A replay of the webcast presentation will be available for 90 days.

About Cepheid

Cepheid (Nasdaq: CPHD), based in Sunnyvale, California, is a molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the clinical, industrial and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See http://www.cepheid.com for more information.

(Logo:

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cepheid Reports Fourth Quarter and Full Year 2007 Results
2. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
3. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
4. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
5. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
6. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
7. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
8. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
9. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
10. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
11. AutoGenomics to Present at Cowen Health Care Conference on March 17, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2008)...ew Jersey, December 5, R...ative molecular diagnostic company leveraging micr...ted financial results for the quarter ended,Septe...e company recorded revenues for the third quarter ... from the date of acquisition of Parkway Clinical,...
(Date:12/5/2008)...-FirstCall/ -- China Sky One Medical,Inc. ("Chin...KI ), a leading,fully integrated pharmaceutical c...ople,s Republic of China ("PRC"), announced today ...t of China Sky One Medical took part in an,insigh...ective. , As a well-known pharmaceutical co...
(Date:12/4/2008)...tCall/ -- Medivation, Inc.,(Nasdaq: MDVN ) toda...hief,executive officer, will be a featured speake...ealthcare Conference on Thursday, December 11, in ...cer" from 8:00-8:55 a.m. Eastern Time, -- "The...5 p.m. Eastern, Time, , A live au...
(Date:12/4/2008)...truction of Synthetic Genomes , , ROCKVILL...ers at the J. Craig Venter Institute (JCVI), a not...blished a paper describing a significant advance i...le the whole bacterial genome, Mycoplasma genital...uthor Daniel G. Gibson, Ph.D. and his team publish...
Breaking Biology Technology:Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 2Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 3Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 4Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 5Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 6Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 7Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 8Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 9Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 10China Sky One Medical, Inc. Interviewed in The China Perspective 2China Sky One Medical, Inc. Interviewed in The China Perspective 3Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference 2J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 2J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 3J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 4J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 5
...aukee, Wis. - For future generations of Native Am...ty could lead through some high-tech corridors. , ...nds is adopting a more aggressive investment strat... technology industry and the state economy. , ,Aft... plant and an IT firmthe Forest County Potawatomi...
...son, Wis. - NimbleGen Systems, Inc. , a producer...ers to work with its advanced technology used for ...company has announced a number of limited-access p...ke Yale University , the University of Californi...n,s chromatin immunoprecipitation (chIP) arrays, w...
...son, Wis. - Following the announcement of increas...ovider of rich-media technology, once again projec... 2006, with full year profitability projected for ...O Ken Minor released upbeat results for Sonic Foun...nce utilizing the company,s synchronized web prese...
... adison, Wis. - Dr. Chuck Rice of Kansas State U...tion in the Midwest will be better farming methods..., thus reducing greenhouse gases. , ,Brendan Jorda...evelopment says production of ethanol and other b...everything from switchgrass to corn stover, will m...
Other Biology Technology:Potawatomis to ramp up their investing 2Potawatomis to ramp up their investing 3NimbleGen partners with leading researchers 2Sonic closer to turning profit corner 2Sonic closer to turning profit corner 3Sonic closer to turning profit corner 4It's not exactly OPEC, but Midwest states are trading ideas on biofuels 2It's not exactly OPEC, but Midwest states are trading ideas on biofuels 3
(Date:12/4/2008)...ofessor of biology in Arts & Sciences, has made a ...cleolar dominance, the silencing of an entire pare...or animal. , Since the machinery involved in n...hat can go haywire in diseases such as cancer, Pik...rtant implications for applied medical research. ...
(Date:12/4/2008)...hers are taking a closer look at the phosphoinosit...nue to demonstrate that inhibiting this biological...ngineering & Biotechnology News ( GEN ). The path...erentiation, and survival. In addition, it is part...le in cancer, according to the December issue of ...
(Date:12/4/2008)...efences and causes disease,by sneakily disabling...led in new research out today (4 December) in Cur...thogen which causes bacterial speck disease,in to...lesions on leaves,and fruit. Severe infection can...s, and researchers believe that understanding more...
(Date:12/4/2008)...isting of skeletal muscle, chronic inflammation of...imbs can result in significant physical impairmen...logy and community health professor Kimberly Huey,...nt properties of Vitamin E may be associated with ...okines, in vitro, in various types of cells. Cytok...
Breaking Biology News(10 mins):Researchers solve piece of large-scale gene silencing mystery 2Researchers solve piece of large-scale gene silencing mystery 3Researchers solve piece of large-scale gene silencing mystery 4Red alert! How disease disables tomato plant's 'intruder alarm' 2Vitamin E shows possible promise in easing chronic inflammation 2Vitamin E shows possible promise in easing chronic inflammation 36 Years Later 9 11 Health Questions Linger 957 16 Years Later 9 11 Health Questions Linger 957 26 Years Later 9 11 Health Questions Linger 957 36 Years Later 9 11 Health Questions Linger 957 46 Years Later 9 11 Health Questions Linger 957 5Jacobs Receives Contract for New Hospital Project in Belgium 952 1Jacobs Receives Contract for New Hospital Project in Belgium 952 2NicOx Reports TOPIGEN to Advance TPI 1020 Into Phase 2 for COPD Following Promising Clinical Results 238 1NicOx Reports TOPIGEN to Advance TPI 1020 Into Phase 2 for COPD Following Promising Clinical Results 238 2NicOx Reports TOPIGEN to Advance TPI 1020 Into Phase 2 for COPD Following Promising Clinical Results 238 3NicOx Reports TOPIGEN to Advance TPI 1020 Into Phase 2 for COPD Following Promising Clinical Results 238 4NicOx Reports TOPIGEN to Advance TPI 1020 Into Phase 2 for COPD Following Promising Clinical Results 238 5China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China 948 1China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China 948 2China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China 948 3
..., researchers have identified the job of one of th...nzyme has puzzled scientists because it is present...is crucial to life, and yet, in laboratory experim...discovery suggests that the enigmatic enzyme known...ent and accurate replication of a particular kind ...
...nted an organ-specific innate immune system. In r...ournal Immunity, scientists at the University of C...line the unique mechanism by which the lung shapes...on. , "This innate immune response is specific to ...llateral damage to lung tissue caused by unchecked...
... system disorder that prevents them from making an...thy and lead productive lives, according to result...,s Research Hospital. A report on this study appea...ology. , The study of 41 adults with X-linked aga...n as relatively healthy, productive individuals, e...
... scientists at the National Institute of Allergy a...titutes of Health (NIH) describe a new understandi...at may lead to new ways of thinking about how to e... vaccines. , Led by immunologist Ronald Germain, M...icroscope to document what happens inside the lymp...
Other Biology News:Common enzyme is a key player in DNA repair 2Common enzyme is a key player in DNA repair 3Researchers reveal lung's unique innate immune system 2Patients now surviving once-fatal immune disease 2Patients now surviving once-fatal immune disease 3Chemical guidance of T cells leads to immunologic memory and long-term immunity 2Chemical guidance of T cells leads to immunologic memory and long-term immunity 3
AM100 is an aqueous-based, permanent mounting media designed for use with alkaline phosphatase and immunoperoxidase stained tissue sections.
... identified as the cellular homolog of the avian s...been shown to be almost identical to c-Jun in thei...zation and DNA binding, whereas their N-terminal d...vation, diverge. Antigen: The antibody was pro...
Rnase Inhibitor from Bioline
Rabbit polyclonal to JAK2 (phospho Y1007) ( Abpromise for all tested applications). Antigen: Synthesized phosphopeptide derived from human JAK2 around the phosphorylation site of tyrosine 1007 (
Biology Products: